Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall summaries highlight that while patients on ocrelizumab may have weaker vaccine responses, vaccination remains recommended; discussion includes mentions of specific vaccine response rates and clinical implications, emphasizing the importance and potential limitations of the findings, often using words like 'important,' 'noted,' and 'recommendation' to convey impact.
Most discussions acknowledge the study’s findings, with many emphasizing the reduced vaccine responses observed in patients on ocrelizumab, yet generally agreeing on the importance of vaccination.
Participants show moderate interest, often referencing specific vaccine responses and the study's implications, but some posts are brief or primarily news-sharing.
There is a moderate level of engagement, with commenters citing details from the study, discussing clinical relevance, or sharing related research, but few delve deeply into methodology or broader impacts.
The collective tone suggests the study is influential in clinical decision-making, with posts mentioning vaccination strategies and potential adjustments in patient care, indicating a recognition of its meaningful impact.
MSニュース、日本では未承認だけど「オクレリズマブ治療中のワクチンの効果」終了。 Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study https://t.co/kP1JzNBYx5
@hollysme Yes. This is specifically studied with Ocrevus in the VELOCE trial: https://t.co/N6ThphDOG0 For instance, "Positive response rate to [the pneumonia vaccine] at 4 weeks was 71.6% [with Ocrevus] and 100% in the control group"
RT @Brandon_Beaber: @hollysme Yes. This is specifically studied with Ocrevus in the VELOCE trial: https://t.co/N6ThphDOG0 For instance, "…
(Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/hS0wwT0Sv6
(Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/hizt6Jctre
(Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/g6r7dkd8JE
The VELOCE study examined how ocrelizumab impacts vaccine efficacy in MS patients, revealing weaker responses to vaccines like tetanus, pneumococcal, and influenza, but vaccination is still recommended to provide some…
The COVID-19 pandemic has caused global health challenges, but vaccines offer hope. This episode explains vaccine basics, immunity, herd immunity, and distribution timelines, with insights on vaccine considerations for…
This episode discusses Covid19 vaccines, their development, and distribution, with insights tailored for the NMO community. It covers vaccine basics, safety, and effectiveness, especially in relation to NMO treatments…
New article: Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/M5tGbOmqjE #MS #multiplesclerosis #neurology https://t.co/RiEcGHgAIt
New article: Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/bWuhUSYU1K #MS #multiplesclerosis #neurology https://t.co/jV6O83Fjn3
New article: Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/5Vz0KxRxdA #MS #multiplesclerosis #neurology https://t.co/s32hNENbUk
(Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/hS0wwT0Sv6
(Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/g6r7dkd8JE
(Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study) https://t.co/hizt6Jctre
Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study - AAN Neurology via BrainSights for iOS https://t.co/FzjZY2ufLJ
Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study - AAN Neurology via BrainSights for iOS https://t.co/qlSWJvndGD
Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study - AAN Neurology via BrainSights for iOS https://t.co/pGcWDMvFCI
Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/7UxavnBaNQ #neurology #doctors #medtwitter #medical #medicinenews #healthcare
Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/Jd5QGFbgdP #neurology #doctors #medtwitter #medical #medicinenews #healthcare
Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study https://t.co/BJmcZemKch #neurology #doctors #medtwitter #medical #medicinenews #healthcare
RT @mscabin: MSニュース、日本では未承認だけど「オクレリズマブ治療中のワクチンの効果」終了。 Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The…
MSニュース、日本では未承認だけど「オクレリズマブ治療中のワクチンの効果」終了。 Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study https://t.co/kP1JzNBYx5
RT @Brandon_Beaber: @hollysme Yes. This is specifically studied with Ocrevus in the VELOCE trial: https://t.co/N6ThphDOG0 For instance, "…
@hollysme Yes. This is specifically studied with Ocrevus in the VELOCE trial: https://t.co/N6ThphDOG0 For instance, "Positive response rate to [the pneumonia vaccine] at 4 weeks was 71.6% [with Ocrevus] and 100% in the control group"
Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis https://t.co/lc2P3O51qP #MultipleSclerosis
Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis https://t.co/AqrJxg8RiB #neurology
Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis https://t.co/jCwsaC6HT5 via @practiceupdate
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study - AAN Neurology via BrainSights for iOS https://t.co/R5Mk4u3DKU
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study https://t.co/eb4fiJUUrp #neurology #doctors #medtwitter #medical #medicinenews #healthcare
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study - PubMed https://t.co/xlxVfu3wRc
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. https://t.co/bpGoWIVfsy https://t.co/0F7pj8ZCdx